Tumor lysis syndrome (TLS) in patients with solid tumors is a rare and potentially fatal
condition associated with anti-cancer treatment. Its outcome depends on awareness …

Gastric cancer is a malignant tumor that ranks third in cancer-related deaths worldwide.
Early-stage gastric cancer can often be effectively managed through surgical resection …

Attempts to furnish antitumor structural templates that can prevent the occurrence of drug-
induced hyperuricemia spurred us to generate xanthine oxidase inhibitor-based hydroxamic …

Background Transplantation of CD34+ hematopoietic stem and progenitor cells (HSPC) into
immunodeficient mice is an established method to generate humanized mice harbouring a …

Spatially fractionated radiation therapy is hypothesized to allow for safe, hypofractionated,
dose-escalated radiation therapy for large tumors. 1, 2, 3 Spatially fractionated radiation …

Background: Tumor lysis syndrome (TLS) is recognized as an oncologic disorder with a
variable incidence. TLS can cause the rapid destruction of tumor cells in response to …

Tumor lysis syndrome, an oncological emergency, is characterized by laboratory parameters
such as hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia, as well as …

B-cell acute lymphoblastic leukemia (B-ALL), a prevalent malignancy predominantly
affecting children, poses challenges such as drug resistance and cytotoxicity despite …

Tumor lysis syndrome is an oncologic emergency caused by the release of intracellular
material, such as potassium, phosphate, and nucleic acids, into the bloodstream from the …

Tumor lysis syndrome (TLS) can be a life-threatening complication that occurs following the
onset of chemotherapy treatment, most commonly in association with high-grade …